A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019

BACKGROUND: It is unknown whether convalescent immunoglobulins (cIgGs) are better than convalescent plasma (CP) for patients with coronavirus 2019 (COVID-19). METHODS: In this randomized controlled trial, we assigned high risk COVID-19 patients with ≤10 days of symptoms, to receive cIgGs or CP. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Maor, Yasmin, Shinar, Eilat, Izak, Marina, Rahav, Galia, Brosh-Nissimov, Tal, Kessler, Asa, Rahimi-Levene, Naomi, Benin-Goren, Odeda, Cohen, Dani, Zohar, Iris, Alagem, Noga, Castro, Sharon, Zimhony, Oren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552585/
https://www.ncbi.nlm.nih.gov/pubmed/37220751
http://dx.doi.org/10.1093/cid/ciad305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552585/
https://www.ncbi.nlm.nih.gov/pubmed/37220751
http://dx.doi.org/10.1093/cid/ciad305

Ejemplares similares